Lparomlimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lparomlimab, covering 2025-08-29 to 2025-08-29. Get the full timeline:
Most recent: Clinical Trial Update: Lparomlimab and Tuvonralimab Injection in Combination With TACE and Lenvatinib in the Treatment of Second-Line Therapy for Unresectable Intermediate-to-Advanced Hepatocellular Carcinoma [Phase 2]